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Summary.-Chinese hamster ovary cells have been treated in vitro with the platinum
coordination complexes cis-PAD or CHIP and with radiation, either alone or in
combination with different doses and time intervals. The isobologram method has
been used to make a graphic comparison of these combined-modality data in terms
of additivity and enhancement. The data showed enhancement of the radiation effect
by these platinum complexes in many combinations, and a truly synergistic effect in
one case. This method of analysis points to the limited usefulness of the parameter
dose-modifying effect (DMF) since the most synergistic combination did not have
the highest DMF.
WE PREVIOUSLY REPORTED that pre-
treatment with cis platinum complexes
PAD [cis-dichlorobis (cyclopentylamine)
platinum (II)] and CHIP (cis-dichlorobis
(isopropylamine) trans-dihydroxy plati-
num (IV)] alters the slope of the X-ray
dose-survival curve for CHO (Chinese
hamster ovary) cells (Szumiel & Nias,
1976b; Nias & Szumiel, 1977). This
alteration was clearly seen when radiation
survival data obtained for drug-pre-
treated cells were normalized to survival
for drug-treated, unirradiated cells and
plotted against radiation dose. The result-
ing survival curves had both a smaller
shoulder and a lower slope than those for
drug-untreated cells, when adequate drug
concentration and timing were applied
(Szumiel & Nias, 1976b).
This difference in slopes of the dose-
survival curves was taken as sufficient
indication of a "more than additive"
effect, or evidence for potentiation (en-
hancement) of radiation action by both
platinum complexes. However, a recent
analysis of terms describing effects of
combined radiation +drug action has been
made by Steel & Peckham (1979), who
constructed isobolograms from single-
agent survival curves, to show the pos-
sible combinations of doses of 2 agents
that could combine in an additive manner
to kill a certain fraction of a cell popula-
tion. Fig. 1 compares this isobologram
method with the simpler form of diagram
which is customarily used.
We have re-evaluated all our data on
the action of Pt complexes+radiation on
rodent cells, using the isobologram
method. The results of this isobologram
analysis are reported below.
MATERIALS AND METHODS
Platinumcomplexes.-Cis-dichlorobis(cyclo-
pentylamine) platinum (II) (cis-PAD) and
cis-dichlorobis (isopropylamine) trans-dihyd-
roxy platinum (IV) (CHIP) were kindly pro-
vided by Dr T. A. Connors and by Johnson
Matthey & Co. Ltd.
Cis-PAD was weighed and initially dis-
solved in dimethylsulphoxide. Subsequent
dilution was made immediately with com-
plete medium. CHIP w%ras weighed, dissolvedISOBOLOGRAMS OF PLATINUM COMPLEXES AND RADIATION
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FIG. 1.-A comparison of: (A) the isobolo-
gram method of Steel & Peckham (1979)
and, (B) the way of estimating the results
of combined treatment with 2 agents as
applied in our previous papers (Szumiel &
Nias, 1976b; Nias & Szumiel, 1977).
in saline and added directly to the cultures
treated. In both cases the Pt-complex solu-
tions were prepared immediately before use.
Cell cultures and treatment conditions.-The
CHO cell culture conditions, drug treatment
and irradiation (y-rays or X-rays) were
described in detail previously (Szumiel &
Nias, 1976a,b). Treatment with Pt complexes
was carried out by addition ofa given volume
of the freshly prepared solution to the cell
culture; after lh incubation at 370C the
medium was changed and cell survival deter-
mined by clone-counting. Irradiation, when
applied, was usually carried out after a
further lh incubation at 37°C (unless other-
wise stated).
RESULTS
Combined CHIP+X-ray treatment (Fig. 2)
The platinum complex CHIP is less
toxic than cis-PAD, as can be seen by
comparing Fig. 2 (Curve 1) with Fig. 4
(Curve 1). These previously unpublished
data were obtained when CHIP was used
with a sub-clone-A2H-of CHO cells
used for chromosome studies (Nias et al.,
1979). For the combination experiment,
CHIP was applied at a dose of 58 p,g/ml
(for 1 h at 37°C) and the survival curve
obtained (Fig. 2, Curve 3) differed clearly
in slope from the radiation survival curve
for untreated cells (Curve 2). In the iso-
bologram analysis, the experimental point
for 2-log cell-kill fell just below the lower
edge ofthe additivity envelope (Fig. 3).
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FIG. 2.-Dose-survival curves for CHO cells,
Clone A2H: 1. CHIP-treated (0); 2. X-
irradiated (0); 3. CHIP-treated (58 jig/ml
for 1 h at 37°C) and X-irradiated after lh
interval (A)'
Time and dose relationships with combined
cis-PAD and y-ray treatment
The experiments described in this sec-
tion were reported briefly by Szumiel &
Nias (1976b) in terms ofDMF values only.
The full cis-PAD and y-ray dose-survival
curves for these cells are presented in
Fig. 4 (Curves 1 and 3 respectively). Both
curves are drawn according to the single-
hit multitarget model, with the initial
slope at low doses of y-rays estimated; the
exponential slopes at higher dose-range
corresponded to mean lethal doses (Do)
1-6 Gy y-rays and 9-2 ,tg/ml (for 1 h at
37°C) of cis-PAD; the extrapolation num-
bers were 2-3 and 6-7 respectively.
Results from the combination experi-
ments are also shown in Fig. 4. When a lh
treatment with 26 ,ug/ml of cis-PAD was
applied 72 or 24 h before irradiation,
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identical survival curves were obtained
(Curve 4) which had the same Do values as
the curve for untreated CHO cells (Curve
3). A 4h and lh interval between cis-PAD
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FIG. 3.-Isobolograms construct
Curves 1 and 2 from Fig. 2 for
2-log cell kill.
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FIG. 4. Dose-survival curves for CHO cells
in MTedium A: 1. cis-PAD-treated (0);
j 1 s 2. y-irradiated (3 Gy) and cis-PAD-treated
150 200 (26 ttg/ml for 1 hi at 370C) after Th interval (LO); 3. y-irradiated (0); 4. cis-PAD-
treated (26 jig/ml for 1 h at 37°C) and y-
irradiated after 72h (V) or 24h(V) interval;
ted using 5. cis-PAD-treated (26 iLg/ml for 1 h at
1-log and 37°C) and y-irradiated after 4 h (A) or lh
(A) interval.
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Fic.. 5. Isobolograms constructedi using Curves 1 and 3 from Fig. 4 for 1-log and 2-log cell kill; cxpcri-
mental points in(iicated for (lifferent treatment schedules, listed in the upper part of the graplh.
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pre-treatment and irradiation also gave
very similar survival curves (shown as the
single Curve 5) which, however, differed in
Do from the curve for untreated cells.
Finally, combined treatment applied in
the reversed sequence (3 Gy of y-rays
followed by drug treatment 2 h later) gave
a dose-survival curve (Curve 2) slightly
different from that for unirradiated, drug-
treated CHO cells (Curve 1).
Using the single-agent curves (1 and 3)
isobolograms were constructed for 1-log
and 2-log cell-kill levels, and all the com-
bination data were plotted in the sequence
of Fig. 5, A-D. As can be seen, all the
experimental points are within the addi-
tivity envelopes, with the exception ofthe
72h and 24h-interval data points, which
touch the upper edge of the envelopes
(Fig. 5D).
DISCUSSION
The results of combined treatment of
CHO and L5178Y cells with Pt complexes
and ionizing radiation were previously
described as "more than additive" or
"additive" (Szumiel & Nias, 1976b; Nias &
Szumiel, 1977; Niepokojczycka & Szumiel,
1979); the degree of additivity was
assessed by summing up the logarithms of
surviving fractions obtained after single-
agent treatment-in other words, by
Mode I (cf. Fig. Ib). In short, any value on
the Mode I line was considered additive
(e.g. all the data for L5178Y cells),
whereas those below the line were de-
scribed as "more than additive" (Szumiel,
1978). Survey of the isobolograms pre-
sented in Figs 3 and 5 indicate that all the
experimental values obtained for CHO
cells, previously taken as indicating a
"potentiation effect" or "more than addi-
tive" effect, lay within the additivity
envelopes, at best on its lower edge, i.e. at
the limit of the supra-additivity area
determined by Steel & Peckham. In one
case, Fig. 3, the value lay below the lower
edge, indicating a supra-additive effect.
Thus, the conclusion of an enhancement
of sensitivity to radiation by Pt complex
treatment was correct in the case of cis-
PAD or CHIP-treated CHO cells. The ex-
ceptions were the 72h and 24h-interval
data, where additive results were ob-
tained (Fig. 5). The sequence of Figs 5,
A-D, illustrates the use of the isobolo-
gram method for choosing optimal time
and dosage in combined-modality treat-
ment regimes.
The isobologram analysis points to the
limited usefulness of the value of dose-
modifying factor (DMF) in estimating the
effect of a combined-modality treatment.
In one example where the DMF value for
CHIP was 1-64 (Nias & Szumiel, 1977) an
isobologram analysis would place the
experimental point in the middle of the
additivity envelope. In the other example
shown here, on the other hand, the DMF
value for CHIP was 1-55, whereas one of
the experimental points fell below the
lower edge of the envelope of additivity
(Fig. 3). The highest DMF value for cis-
PAD was only 1-59 (Szumiel & Nias,
1976b); nevertheless, in this case the ex-
perimental point would be close to the
Mode II line. Thus, one cannot predict
from the DMF value whether the effect is
"enhanced" or "supra-additive" in terms
proposed by Steel & Peckham (1979). It
should be added that other survival data
from experiments on the combined treat-
ment of CHO, L5178Y-R and L5178Y-S
cells with cis-PAD and X-rays (Szumiel &
Nias, 1976b; Niepokojczycka & Szumiel,
1979) have also been analysed by the
isobologram method. For the sake of
brevitythe results are not shown, but they
support the main conclusions.
Generally it can be stated that the iso-
bologram analysis, as proposed by Steel &
Peckham (1979), has confirmed our pre-
vious conclusions of an enhanced effect of
the combination of Pt-complex treatment
with irradiation, although a supra-additive
effect has not generally been demon-
strated. Isobologram analysis can help to
indicate the optimal dose-time relation-
ship in a combined-modality regime of
cytotoxic therapy when complete dose-
response data are available for each
modality of treatment, an essential pre-
295296 I. SZUMIEL AND A. H. W. NIAS
requisite for the optimization of such
combinations (Nias, 1976).
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